Showing results (1-10 of 271) with videos related to
Sort By:
Pageof 28
Transplantation|November 25, 2015
Potential Roles for C1 Inhibitor in TransplantationMel Berger, William M Baldwin, Stanley C JordanTransplantation|April 5, 2019
Update on C1 Esterase Inhibitor in Human Solid Organ TransplantationMel Berger, Carmen Lefaucheur, Stanley C JordanTransplantation Direct|February 21, 2024
Assessment of IgM DSAs in Transplant Recipients: Relationship to De Novo IgG DSAs and Risk for Antibody RejectionXiaohai Zhang, Stanley C JordanKidney International|March 22, 2022
Donor-derived cell-free DNA in kidney transplantation: evolving concepts and potential limitationsEdmund Huang, Stanley C JordanCurrent Opinion in Organ Transplantation|December 29, 2022
Novel therapies for treatment of antibody-mediated rejection of the kidneySupreet Sethi, Stanley C JordanClinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Presensitization: the problem and its managementStanley C Jordan, Mark D PescovitzCurrent Opinion in Organ Transplantation|October 12, 2014
Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approachesStanley C Jordan, Ashley A VoPediatric Transplantation|February 24, 2024
Management of the sensitized pediatric renal transplant candidateDechu P Puliyanda, Stanley C JordanTransplantation Reviews (Orlando, Fla.)|April 14, 2009
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejectionKazunori Murata, William M BaldwinPediatric Nephrology (Berlin, Germany)|June 25, 2005
Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directionsAsha Moudgil, Arvind Bagga, Stanley C JordanPageof 28